Form D — SonoThera, Inc.

0001945154-26-000002 · filed Jun 30, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06c
Reported offering amount: $125,450,218
Reported amount sold: $125,450,218
Minimum investment: $0
Investors: 22
Sales commission: $0
Finders' fees: $0

Issuer

Name: SonoThera, Inc.
CIK: 1945154
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2021
Address: 201 HASKINS WAY, 5TH FLOOR
SOUTH SAN FRANCISCO, CA 94080
Phone: 510-414-2997

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Kenneth Greenberg · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
Michael Davidson · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
Steven Gillis · Director

South San Francisco, CA Find on LinkedIn ↗
Brian Halak · Director

South San Francisco, CA Find on LinkedIn ↗
Rajul Jain · Director

South San Francisco, CA Find on LinkedIn ↗
Rakhshita Dhar · Director

South San Francisco, CA Find on LinkedIn ↗
Steven Feinstein · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
Carolyne Zimmerman · Executive Officer

South San Francisco, CA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗